1. Yoon HJ, Choi HY, Ki M. Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea. BMC Infect Dis. 2017;17(1):432. doi: 10.1186/
s12879-017-2532-2534.
2. Kumar K, Loebinger MR. Nontuberculous mycobacterial pulmonary disease: Clinical epidemiologic features, risk factors, and diagnosis. The nontuberculous mycobacterial series. Chest.
2022;161(3):637-646. doi: 10.1016/j.chest.2021.10.003.
3. Hayman J. Mycobacterium ulcerans: an infection from Jurassic time. Lancet. 1984;2(8410)1015-1016.
4. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979;119(1):107–159.
5. Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patient without HIV infection. Chest. 2004;126(2):566–581. doi: 10.1378/chest.126.2.566.
6. LPSN. Cins Mycobacterium Sudbury, Massachusetts2023. https://lpsn.dsmz.de/genus/mycobacterium
7. Yoon J-K, Kim TS Kim JI Yim J-J. Whole genome sequencing of Nontuberculous Mycobacterium (NTM) isolates from sputum specimens of co-habiting patients with NTM pulmonary
disease and NTM isolates from their environment. BMC Genomics. 2020;21:322. doi: 10.1186/s12864-020-6738-2.
8. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/ IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med.
2007;175(4):367-416. doi: 10.1164/rccm.200604-571ST.
9. Hamed KA, Tillotson G. A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges. Expert Rev Respir Med,
2023;17(11):973-988. doi: 10.1080/17476348.2023.2283135.
10. Rocha D, Felgueires O, Duarte R. Can environmental determinants explain Nontuberculous Mycobacteria geographic incidence? Pulmonology. 2020;26(3):145-150. doi: 10.1016/j.pul-
moe.2019.12.003.
11. Kadota N, Shinohara T, Hino H, et al. Mycobacterium abscessus ssp. abscessus infection progressing to empyema from vertebral osteomyelitis in an immunocompetent patient without pul-
monary disease: a case report. BMC Pulm Med 2019;19:100, doi: 10.1186 / s12890-019-0860-4.
12. Piersimon C, Scarparo C. Extrapulmonary Infections Associated with Nontuberculous Mycobacteria in Immunocompetent Persons. Emerg Infect Dis. 2009 Sep; 15(9): 1351–1358.
doi: 10.3201/eid1509.081259.
13. Yu JA, Pomerantz M, Bishop A, Weyant MJ, Mitchell JD. Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiec-
tasis associated with nontuberculous mycobacterial disease Eur J Cardiothorac Surg 2011;40(3):671–675. doi: 10.1016/j.ejcts.2010.12.028.
14. Varley CD, Winthrop KL. Nontuberculous mycobacteria: Diagnosis and therapy. Clin Chest Med. 2022;43(1):89-98. doi: 10.1016/j.ccm.2021.11.007.
15. Chen L, Arens R, Chidambaram AG, et al. Vaping associated pulmonary nontuberculous mycobacteria. Lung. 2021;199(1):21-27. doi: 10.1007/s00408-020-00414-6.
16. Kim Y, Yoon JH, Ryu J, et al. Gastroesophageal reflux disease increases susceptibility to nontuberculous mycobacterial pulmonary disease. Chest. 2023;163(2):270-280. doi: 10.1016/j.
chest.2022.08.2228.
17. Goulabchand R, Makinson A, Morel J et al. Hospitalizations for infections in primary Sjogren’s syndrome patients: a nationwide incidence study. Ann Med. 2022;54(1):2672-2680. doi:
10.1080/07853890.2022.2126517.
18. Anton C, Machado FD, Ramirez JMA, et al. Latent tuberculosis infection in patients with rheumatic disease J Bras Pneumol. 2019;45(2): e20190023. doi: 10.1590/1806-3713/e20190023.
19. Mycobacteria. In: Koneman’s color atlas and textbook of diagnostic microbiology. Ed’s: Procop GW, Church DL, Hall GS, Janda WM, Koneman EW, Schreckenberger PC, Woods GL. Myco-
bacteria. 2017. p. 1219–1268. Seventh ed. Philadelphia: Wolters Kluwer Health.
20. Woods GL, Washington JA. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis. 1987;9(2):275–294.
21. Gupta RS, Lo B, Son J. Corrigendum: phylogenomics and comparative genomic studies robustly support division of the genus Mycobacterium into an emended genus Mycobacterium and
four novel genera. Front Microbiol 2019;(10):714. doi: 10.3389/fmicb.2019.00714.
22. Tortoli E, Brown-Elliott BA, Chalmers JD, et al. Same meat, different gravy: ignore the new names of mycobacteria. Eur Respir J. 2019;54(1). 1900795; doi: 10.1183/13993003.00795-2019
23. Oren A, Trujillo ME. On the valid publication of names of mycobacteria. Eur Respir J. 2019;54(4). 1901623. doi: 10.1183/13993003.01623-2019.
24. Khare R, Brown-Elliott BA. Culture, Identification, and Antimicrobial Susceptibility Testing of Pulmonary Nontuberculous Mycobacteria. Clin Chest Med. 2023;44(4):743-755. doi: 10.1016/j.
ccm.2023.06.001.
25. Shinohara T, Morizumi S, Sumitomo K. Varying clinical presentations of nontuberculous mycobacterial disease: Similar to but different from tuberculosis. J Med Invest. 2021;68(3.4):220-
227. doi: 10.2152/jmi.68.220.
26. Nogueira LB, Garcia CN, Costa MSCD et al. Non-tuberculous cutaneous mycobacterioses. An Bras Dermatol. 2021;96(5):527-538. doi: 10.1016/j.abd.2021.04.005.
27. Yan M, Brode SK, MD, Marras TK. The Other Nontuberculous Mycobacteria Clinical Aspects of Lung Disease Caused by Less Common Slowly Growing Nontuberculous Mycobacteria
Species. Chest. 2023;163(2):281-291. doi: 10.1016/j.chest.2022.09.025.
28. Penn R, Steehler MK, Sokohl A, Harley EH. Nontuberculous mycobacterial cervicofacial lymphadenitis- a review and proposed classification system, Int J Pediatr Otolaryngol. 2011;75(12):
1599–1603. doi: 10.1016/j.ijporl.2011.09.018.
29. Spinelli G, Mannelli G, Arcuri F et al. Surgical treatment for chronic cervical lymphadenitis in children – experience from a tertiary care paediatric centre on non-tuberculous mycobacterial
infections, Int J Pediatr Otolaryngol. 2018(108):137–142. doi: 10.1016/j.ijporl.2018.02.042.
30. Ulusal Mikrobiyoloji Standartları: Ulusal tüberküloz laboratuvar tanı rehberi (UTLR). Editörler: Aslan G, Arslantürk A, Ceyhan İ, Esen N, Özkütük A, Özkütük N, Şatana D, Uçarman SN.
Sağlık Bakanlığı
31. Mentula S, Paakkanen J, Hyyryläinen H-L. External quality assessment by European mycobacterial laboratories: results of AFB microscopy and identification rounds. Diagn Microbiol Infect
Dis. 2022;104(2):115757. doi: 10.1016/j.diagmicrobio.2022.115757.
32. Forbes BA, Miller MB, Banai N, et al. M48 Laboratory detection and identification of Mycobacteria. 2018, 2. baskı. Clinical and laboratory standards institute.
33. Preece CL, Wichelhaus TA, Perry A et al. Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis. J Clin Microbiol.
2016;4(7):1797-1803. doi: 10.1128/JCM.00471-16.
34. Alexander KJ, Furlong JL, Baron JL et al. Evaluation of a new culture medium for isolation of nontuberculous mycobacteria from environmental water samples. PLoS One. 2021;3;16(3):e0247166.
doi: 10.1371/journal.pone.0247166.
35. Rotcheewaphan S, Odusanya OE, Henderson CM et al. Performance of RGM Medium for Isolation of Nontuberculous Mycobacteria from Respiratory Specimens from Non-Cystic Fibrosis
Patients. J Clin Microbiol. 2019;57(2):e01519-18. doi: 10.1128/JCM.01519-18.
36. Woods GL, Wengenack NL, Lin G, et al. M24 Susceptibility testing of Mycobacteria, Nocardia spp., and other aerobic Actinomycetes, 2018, 3rd Edition. Clinical and laboratory standards
institute.
37. Saleeb PG, Drake SK, Murray PR, Zelazny AM. Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin
Microbiol. 2011;49(5):1790–1794. doi: 10.1128/JCM.02135-10.
38. Alcaide F, Amlerová J, Bou G, et al. How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry. Clin Microbiol Infect. 2018;24(6):599–603. doi:
10.1016/j.cmi.2017.11.012.
39. Butler WR, Guthertz LS. Mycolic acid analysis by high-performance liquid chromatography for identification of mycobacterium species. Clin Microbiol Rev. 2001;14(4):704–726. doi:
10.1128/CMR.14.4.704-726.2001.
40. Lee AS, Jelfs P, Sintchenko V, Gilbert GL. Identification of non-tuberculous mycobacteria: Utility of the GenoType Mycobacterium CM/AS assay compared with HPLC and 16S rRNA gene
sequencing. J Med Microbiol. 2009;58(7):900–904. doi: 10.1099/jmm.0.007484-0.
41. Kim SH, Shin JH. Identification of nontuberculous mycobacteria using multilocous sequence analysis of 16S rRNA, hsp65, and rpoB. J Clin Lab Anal. 2018;32(1):1–6. doi: 10.1002/jcla.22184.
42. Pai S, Esen N, Pan X, Musser JM. Routine rapid Mycobacterium species assignment based on species-specific allelic variation in the 65-kilodalton heat shock protein gene (hsp65). Arch Pathol
Lab Med. 1997;121(8):859-864.
43. Perkins KM, Lawsin A, Hasan NA, et al. Notes from the field: Mycobacterium chimaera contamination of heater-cooler devices used in cardiac surgery – United States. MMWR Morb Mortal
Wkly Rep 2016;65(40):1117–1118. doi: 10.15585/mmwr.mm6540a6.
44. Appak Ö, Türkel S, Esen N, Özkütük AA. Comparison of polymerase chain reaction-restriction enzyme analysis method and DNA sequence analysis results in the identification of non-tu-
berculous mycobacteria. Acta Microbiol Immunol Hung. 2018;65(4):515-527. doi: 10.1556/030.65.2018.027.
45. Tortoli E, Mariottini A, Mazzarelli G. Evaluation of INNO-LiPA MYCOBACTERIA v2: Improved reverse hybridization multiple DNA probe assay for mycobacterial identification. J Clin
Microbiol. 2003;41(9):4418–4420. doi: 10.1128/JCM.41.9.4418-4420.2003.
46. Fukushima M, Kakinuma K, Hayashi H, Nagai H, Ito K, Kawaguchi R. Detection and identification of Mycobacterium species isolates by DNA microarray. J Clin Microbiol. 2003;41(6):2605–
2615. doi: 10.1128/JCM.41.6.2605-2615.2003.
47. Woods GL, Wengenack NL, Lin G, et al. M62 Performance standards for Susceptibility Testing of Mycobacteria, Nocardia spp. and Other Aerobic Actinomycetes, 2018, 1st Edition. Clinical
and laboratory standards institute.
48. Özkarataş MH, Arslan N, Esen N, Özkütük AA. Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria. Mikrobiyol Bul. 2023;57(2):220-237. doi: 10.5578/mb.20239917.
49. Brown-Elliott BA, Wallace RJ Jr, Wengenack NL, et al. Emergence of inducible macrolide resistance in Mycobacterium chelonae due to broad-host-range plasmid and chromosomal variants
of the novel 23S rRNA methylase gene erm(55). J Clin Microbiol. 2023;61(7): e0042823. doi: 10.1128/jcm.00428-23.
50. van Ingen J, Wagner D, Gallagher J, et al. Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases. Eur Respir J. 2017;49(2):160 doi:
10.1183/13993003.01855-2016.1855.